Atlas Trials

Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults

Clinical trial NCT03483961 · COMPLETED

Trial details

NCT number
NCT03483961
Sponsor
Bavarian Nordic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chikungunya Virus Infection
Start date
2018-04-18
Primary completion
2020-09-14
Enrollment
445

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.